Intangible Assets and Impairment of Long-Lived Assets (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

	Remaining Amortization Period	As of December 31, 2022							As of December 31, 2021
	in Years at December 31, 2022	Gross Asset Value		Accumulated Amortization			Net Carrying Value		Gross Asset Value		Accumulated Amortization			Net Carrying Value
Licensed patents	13.5	$	596,259	$	(142,654	)	$	453,605	$	603,919	$	(110,759	)	$	493,160
Technology license	16.6		1,485,159		(279,906	)		1,205,253		1,658,550		(202,797	)		1,455,753
		$	2,081,418	$	(422,560	)	$	1,658,858	$	2,262,469	$	(313,556	)	$	1,948,913

Schedule of future amortization related to intangible assets

For the Years Ending December 31,
2023	$	109,489
2024		109,489
2025		109,489
2026		109,489
2027		109,489
Thereafter		1,111,413
	$	1,658,858

Schedule of goodwill activity

	CBR Pharma Goodwill			180 LP Goodwill			Consolidated Goodwill
Balance, December 31, 2021	$	23,749,631		$	13,238,255		$	36,987,886
Currency translation		(664,353	)		-			(664,353	)
Balance, March 31, 2022		23,085,278			13,238,255			36,323,533
Currency translation		(1,734,582	)		-			(1,734,582	)
Balance, June 30, 2022		21,350,696			13,238,255			34,588,951
Currency translation		(1,750,386	)		-			(1,750,386	)
Balance before impairment		19,600,310			13,238,255			32,838,565
Impairment of goodwill		(11,264,612	)		(7,608,238	)		(18,872,850	)
Balance, September 30, 2022		8,335,698			5,630,017			13,965,715
Currency translation		708,713			-			708,713
Balance before impairment		9,044,411			5,630,017			14,674,428
Impairment of goodwill		(9,044,411	)		(5,630,017	)		(14,674,428	)
Balance, December 31, 2022	$	-		$	-		$	-

	CBR Pharma IP R&D Assets			180 LP IP R&D Assets			Consolidated IP R&D Assets
Balance, December 31, 2021	$	1,632,780		$	10,943,000		$	12,575,780
Currency translation		(45,674	)		-			(45,674	)
Balance, March 31, 2022		1,587,106			10,943,000			12,530,106
Currency translation		(119,252	)		-			(119,252	)
Balance, June 30, 2022		1,467,854			10,943,000			12,410,854
Currency translation		(120,338	)		-			(120,338	)
Balance, September 30, 2022		1,347,516			10,943,000			12,290,516
Currency translation		114,568			-			114,568
Balance before impairment		1,462,084			10,943,000			12,405,084
Impairment of IP R&D assets		(1,462,084	)		(1,880,000	)		(3,342,084	)
Balance, December 31, 2022	$	-		$	9,063,000		$	9,063,000